OrbiMed Advisors, LLC
Latest statistics and disclosures from ORBIMED ADVISORS's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALXN, BIIB, CELG, BSX, MRK, and represent 22.47% of ORBIMED ADVISORS's stock portfolio.
- Added to shares of these 10 stocks: CNC (+$117.99M), MRK (+$69.87M), AET (+$64.60M), Mylan Nv (+$50.69M), Wright Medical Group Nv (+$50.16M), EW (+$45.90M), BIIB (+$42.57M), ACAD (+$40.19M), Global Blood Therapeutics In (+$39.96M), BMY (+$39.02M).
- Started 16 new stock positions in ALNY, ACAD, Alkermes Plc, Radius Health, Obseva Sa, Mylan Nv, Aurinia Pharmaceuticals, Global Blood Therapeutics In, Sierra Oncology, CNC. Medigus Ltd sponsord, Nevro, Wright Medical Group Rtsn V, Sarepta Therapeutics, Heron Therapeutics, Orexigen Therapeutics Inc note 2.750%12/0 added.
- Reduced shares in these 10 stocks: AMGN (-$146.60M), NBIX (-$73.07M), ISRG (-$72.89M), Allergan (-$69.84M), Abbvie (-$55.06M), SHPGY (-$53.30M), TMO (-$40.75M), HUM (-$40.01M), BSX (-$29.73M), .
- Sold out of its positions in ABT, AMED, Aralez Pharmaceuticals Inc Com stock, Forward Pharma A/s, Incyte Corp note 0.375%11/1, Incyte Corp. note 1.250 11/1, Inotek Pharmaceuticals, Medigus, MOH, Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0. Ptc Therapeutics I, Portola Pharmaceuticals, SGMO, Ultragenyx Pharmaceutical.
- ORBIMED ADVISORS was a net buyer of stock by $59.45M.
- ORBIMED ADVISORS has $8.82B in assets under management (AUM), growing by 12.41%.
ORBIMED ADVISORS portfolio companies for March 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Alexion Pharmaceuticals (ALXN) | 5.17 | 3.76M +7.00% | 121.24 | 98.50 |
| Biogen Idec (BIIB) | 4.45 | 1.44M +12.00% | 273.42 | 252.97 |
| Celgene Corporation (CELG) | 4.42 | 3.13M | 124.43 | 116.74 |
| Boston Scientific Corporation (BSX) | 4.32 | 15.31M -7.00% | 24.87 | 27.26 |
| Merck & Co (MRK) | 4.12 | 5.71M +23.00% | 63.54 | 65.04 |
| Wright Medical Group Nv | 3.24 | 9.20M +21.00% | 31.12 | 0.00 |
| Eli Lilly & Co. (LLY) | 3.17 | 3.33M +15.00% | 84.11 | 78.34 |
| Incyte Corporation (INCY) | 2.99 | 1.97M -5.00% | 133.67 | 138.41 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.69 | 2.17M | 109.35 | 118.60 |
| Amgen (AMGN) | 2.67 | 1.44M -38.00% | 164.07 | 155.43 |
| Agilent Technologies Inc C ommon | 2.18 | 3.63M | 52.87 | 0.00 |
| Pfizer (PFE) | 2.10 | 5.41M +4.00% | 34.21 | 32.16 |
| Edwards Lifesciences (EW) | 1.96 | 1.84M +36.00% | 94.07 | 114.17 |
| Aetna (AET) | 1.90 | 1.31M +62.00% | 127.55 | 145.23 |
| Shire (SHPGY) | 1.77 | 897451 -25.00% | 174.23 | 0.00 |
| HCA HOLDINGS Inc | 1.76 | 1.75M -12.00% | 88.99 | 0.00 |
| Humana (HUM) | 1.73 | 742300 -20.00% | 206.14 | 232.23 |
| Regeneron Pharmaceuticals (REGN) | 1.66 | 378170 +6.00% | 387.51 | 455.70 |
| Anthem | 1.62 | 862600 -15.00% | 165.38 | 0.00 |
| Abbvie | 1.54 | 2.08M -28.00% | 65.16 | 0.00 |
| Array BioPharma (ARRY) | 1.44 | 14.18M -11.00% | 8.94 | 8.27 |
| Ironwood Pharmaceuticals (IRWD) | 1.40 | 7.24M | 17.06 | 19.07 |
| Bristol Myers Squibb (BMY) | 1.36 | 2.21M +48.00% | 54.38 | 54.39 |
| Centene Corporation (CNC) | 1.34 | 1.66M NEW | 71.26 | 75.25 |
| Intercept Pharmaceuticals In | 1.33 | 1.04M -7.00% | 113.10 | 0.00 |
| Allergan | 1.29 | 477390 -37.00% | 238.92 | 0.00 |
| BioMarin Pharmaceutical (BMRN) | 1.27 | 1.27M | 87.78 | 87.33 |
| Corvus Pharmaceuticals | 1.27 | 5.38M | 20.77 | 0.00 |
| Johnson & Johnson (JNJ) | 1.25 | 884600 +3.00% | 124.55 | 127.53 |
| SYNERGY PHARMACEUTICALS | 1.12 | 21.15M +15.00% | 4.66 | 0.00 |
| Tenet Healthcare Corporation stock | 1.07 | 5.35M +43.00% | 17.71 | 0.00 |
| Glaukos | 1.01 | 1.74M -20.00% | 51.30 | 0.00 |
| Insmed Inc | 0.95 | 4.81M -9.00% | 17.51 | 0.00 |
| Puma Biotechnology Inc Common Stock | 0.95 | 2.25M | 37.20 | 0.00 |
| Thermo Fisher Scientific (TMO) | 0.93 | 534200 -33.00% | 153.60 | 172.90 |
| Audentes Therapeutics Inc Com stock | 0.93 | 4.80M | 17.04 | 0.00 |
| Viewray | 0.91 | 9.46M +3.00% | 8.51 | 0.00 |
| Ascendis Pharma A S | 0.86 | 2.72M | 28.00 | 0.00 |
| Magellan Health Services (MGLN) | 0.85 | 1.09M +35.00% | 69.05 | 69.40 |
| Allergan Plc pfd conv ser a | 0.85 | 88200 | 848.44 | 0.00 |
| Loxo Oncology | 0.82 | 1.73M | 42.08 | 0.00 |
| Aerie Pharmaceuticals | 0.77 | 1.50M | 45.35 | 0.00 |
| Mallinckrodt Pub | 0.74 | 1.47M | 44.57 | 0.00 |
| Insys Therapeutics | 0.72 | 6.07M | 10.51 | 0.00 |
| Medtronic | 0.70 | 766600 | 80.56 | 0.00 |
| Gw Pharmaceuticals Plc ads | 0.65 | 475900 +19.00% | 120.94 | 0.00 |
| Achillion Pharmaceuticals (ACHN) | 0.63 | 13.11M | 4.21 | 4.15 |
| Eagle Pharmaceuticals | 0.63 | 671000 | 82.94 | 0.00 |
| Gilead Sciences (GILD) | 0.62 | 800900 -24.00% | 67.92 | 64.56 |
| Illumina (ILMN) | 0.62 | 321900 +76.00% | 170.64 | 173.76 |
| Jazz Pharmaceuticals | 0.61 | 371400 | 145.13 | 0.00 |
| Newlink Genetics Corporation | 0.60 | 2.19M +10.00% | 24.10 | 0.00 |
| Mylan Nv | 0.57 | 1.30M NEW | 38.99 | 0.00 |
| UnitedHealth (UNH) | 0.55 | 296400 | 164.01 | 178.05 |
| Immunomedics Inc note 4.750% 2/1 | 0.48 | 30.00M | 1.41 | 0.00 |
| Stryker Corporation (SYK) | 0.47 | 316300 | 131.65 | 140.85 |
| ACADIA Pharmaceuticals (ACAD) | 0.46 | 1.17M NEW | 34.38 | 26.27 |
| Global Blood Therapeutics In | 0.45 | 1.08M NEW | 36.85 | 0.00 |
| Intuitive Surgical (ISRG) | 0.44 | 50400 -65.00% | 766.47 | 907.57 |
| Cooper Companies (COO) | 0.43 | 190800 -23.00% | 199.89 | 218.32 |
| Intellia Therapeutics Inc Com stock | 0.43 | 2.66M | 14.09 | 0.00 |
| Dermira | 0.40 | 1.02M +140.00% | 34.11 | 0.00 |
| Beigene | 0.38 | 903700 | 36.61 | 0.00 |
| Assembly Biosciences | 0.36 | 1.26M -10.00% | 25.49 | 0.00 |
| Sarepta Therapeutics | 0.35 | 1.05M NEW | 29.60 | 0.00 |
| Momenta Pharmaceuticals (MNTA) | 0.32 | 2.11M -28.00% | 13.35 | 15.00 |
| Select Medical Holdings Corporation (SEM) | 0.32 | 2.09M +150.00% | 13.35 | 13.90 |
| Radius Health | 0.31 | 704100 NEW | 38.65 | 0.00 |
| Obseva Sa | 0.31 | 2.61M NEW | 10.41 | 0.00 |
| Selecta Biosciences | 0.30 | 1.84M | 14.32 | 0.00 |
| Bluebird Bio | 0.29 | 283800 | 90.90 | 0.00 |
| Lion Biotechnologies | 0.29 | 3.38M | 7.45 | 0.00 |
| Galapagos Nv-spon | 0.28 | 283500 | 86.19 | 0.00 |
| ImmunoGen (IMGN) | 0.27 | 6.10M | 3.87 | 5.07 |
| Otonomy | 0.26 | 1.85M | 12.25 | 0.00 |
| Coherus Biosciences | 0.26 | 1.08M +27.00% | 21.15 | 0.00 |
| eHealth (EHTH) | 0.25 | 1.82M | 12.04 | 17.88 |
| Xencor | 0.23 | 840237 | 23.92 | 0.00 |
| Nabriva Therapeutics Ag | 0.23 | 1.68M | 12.00 | 0.00 |
| Neurocrine Biosciences (NBIX) | 0.22 | 441341 -79.00% | 43.30 | 48.65 |
| Pieris Pharmaceuticals | 0.21 | 7.26M | 2.60 | 0.00 |
| Dbv Technologies S A | 0.20 | 512900 +48.00% | 35.22 | 0.00 |
| Steadymed Ltd shs | 0.20 | 3.07M | 5.80 | 0.00 |
| SINOVAC BIOTECH LTD Com | 0.17 | 2.67M | 5.73 | 0.00 |
| C.R. Bard (BCR) | 0.16 | 58000 | 248.53 | 308.59 |
| EXACT Sciences Corporation (EXAS) | 0.16 | 602900 -36.00% | 23.62 | 33.19 |
| Teva Pharmaceutical Industries (TEVA) | 0.15 | 412600 -32.00% | 32.09 | 28.71 |
| Aurinia Pharmaceuticals | 0.15 | 1.80M NEW | 7.34 | 0.00 |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.14 | 15.00M +87.00% | 0.82 | 0.00 |
| Proqr Thrapeutics N V shs euro | 0.13 | 2.31M | 5.00 | 0.00 |
| Natera | 0.13 | 1.28M | 8.87 | 0.00 |
| Infinity Pharmaceuticals (INFI) | 0.12 | 3.25M | 3.23 | 1.74 |
| Adaptimmune Therapeutics | 0.12 | 1.91M +164.00% | 5.51 | 0.00 |
| Wright Medical Group Rtsn V | 0.12 | 6.90M NEW | 1.53 | 0.00 |
| Aeglea Biotherapeutics | 0.12 | 1.47M +8.00% | 7.45 | 0.00 |
| D Fluidigm Corp Del | 0.11 | 1.75M | 5.69 | 0.00 |
| Heron Therapeutics | 0.11 | 650000 NEW | 15.00 | 0.00 |
| Dimension Therapeutics | 0.11 | 5.40M | 1.75 | 0.00 |
| NuVasive (NUVA) | 0.10 | 123500 | 74.68 | 75.78 |
| Alkermes Plc | 0.10 | 145000 NEW | 58.50 | 0.00 |
| Cellectis S A sponsored ads | 0.10 | 350000 | 24.00 | 0.00 |
| Immunomedics (IMMU) | 0.09 | 1.23M -67.00% | 6.47 | 7.47 |
| Crispr Therapeutics Ag | 0.09 | 372191 | 21.77 | 0.00 |
| Tesaro | 0.08 | 47200 | 153.88 | 0.00 |
| Fluidigm Corporation convertible cor | 0.08 | 10.00M | 0.68 | 0.00 |
| Nevro | 0.08 | 77800 NEW | 93.70 | 0.00 |
| Syndax Pharmaceuticals | 0.08 | 484800 -35.00% | 13.72 | 0.00 |
| Zimmer Holdings (ZMH) | 0.07 | 49000 | 122.10 | 113.56 |
| Redhill Biopharma Ltd cmn | 0.06 | 564900 | 9.59 | 0.00 |
| Minerva Neurosciences | 0.06 | 704300 +26.00% | 8.10 | 0.00 |
| Invitae | 0.06 | 456666 | 11.06 | 0.00 |
| Sierra Oncology | 0.06 | 3.70M NEW | 1.53 | 0.00 |
| Alnylam Pharmaceuticals (ALNY) | 0.05 | 82200 NEW | 51.25 | 69.50 |
| Affimed Therapeutics B V | 0.05 | 2.02M -40.00% | 2.30 | 0.00 |
| Sientra | 0.05 | 522257 -29.00% | 8.42 | 0.00 |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.05 | 7.00M | 0.63 | 0.00 |
| Roka Bioscience | 0.04 | 893470 | 3.56 | 0.00 |
| Xenon Pharmaceuticals | 0.03 | 634812 -36.00% | 4.00 | 0.00 |
| Clearside Biomedical | 0.03 | 300000 | 7.94 | 0.00 |
| Orexigen Therapeutics Inc note 2.750%12/0 added | 0.03 | 5.21M NEW | 0.50 | 0.00 |
| Valeant Pharmaceuticals Int (VRX) | 0.02 | 194900 | 11.03 | 12.79 |
| Vanda Pharmaceuticals (VNDA) | 0.01 | 50200 -93.00% | 14.00 | 14.05 |
| Amarin Corporation (AMRN) | 0.01 | 350000 | 3.20 | 3.05 |
| Biolinerx Ltd-spons Adr | 0.01 | 1.04M | 0.96 | 0.00 |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.01 | 500000 | 1.13 | 0.00 |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.01 | 500000 | 1.19 | 0.00 |
| Marinus Pharmaceuticals | 0.01 | 567600 | 1.77 | 0.00 |
| Noveliontherapeutics | 0.01 | 100000 | 10.74 | 0.00 |
| Alimera Sciences (ALIM) | 0.00 | 250000 | 1.40 | 1.46 |
| Xtant Med Holdings | 0.00 | 475439 | 0.62 | 0.00 |
| Medigus Ltd sponsord | 0.00 | 60000 NEW | 3.08 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for ORBIMED ADVISORS
- ORBIMED ADVISORS 2016 Q4 filed Feb. 14, 2017
- ORBIMED ADVISORS 2016 Q3 filed Nov. 14, 2016
- ORBIMED ADVISORS 2016 Q2 filed Aug. 15, 2016
- ORBIMED ADVISORS 2016 Q1 filed May 16, 2016
- ORBIMED ADVISORS 2015 Q4 filed Feb. 16, 2016
- ORBIMED ADVISORS 2015 Q3 amended filed Nov. 18, 2015
- ORBIMED ADVISORS 2015 Q3 filed Nov. 13, 2015
- ORBIMED ADVISORS 2015 Q2 amended filed Aug. 20, 2015
- ORBIMED ADVISORS 2015 Q1 filed May 15, 2015
- ORBIMED ADVISORS 2014 Q4 filed Feb. 13, 2015
- ORBIMED ADVISORS 2014 Q3 filed Nov. 14, 2014
- ORBIMED ADVISORS 2014 Q2 filed Aug. 14, 2014
- ORBIMED ADVISORS 2014 Q1 filed May 15, 2014
- ORBIMED ADVISORS 2013 Q4 filed Feb. 14, 2014
- ORBIMED ADVISORS 2013 Q3 filed Nov. 14, 2013
- ORBIMED ADVISORS 2013 Q2 filed Aug. 14, 2013
- OrbiMed Advisors 2013 Q1 filed May 15, 2013
- OrbiMed Advisors 2012 Q4 amended filed April 17, 2013
- OrbiMed Advisors 2012 Q4 amended filed Feb. 22, 2013